BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 15476274)

  • 1. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ telomerase activity in pancreatic juice may discriminate pancreatic cancer from other pancreatic diseases.
    Uehara H; Nakaizumi A; Iishi H; Takenaka A; Eguchi H; Ohigashi H; Ishikawa O
    Pancreas; 2008 Apr; 36(3):236-40. PubMed ID: 18362835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
    Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
    Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
    Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis.
    Suehara N; Mizumoto K; Tanaka M; Niiyama H; Yokohata K; Tominaga Y; Shimura H; Muta T; Hamasaki N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2479-83. PubMed ID: 9815650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations.
    Uehara H; Nakaizumi A; Tatsuta M; Baba M; Takenaka A; Uedo N; Sakai N; Yano H; Iishi H; Ohigashi H; Ishikawa O; Okada S; Kakizoe T
    Am J Gastroenterol; 1999 Sep; 94(9):2513-8. PubMed ID: 10484017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of pancreatic cancer by cytology and telomerase activity in exfoliated cells obtained by pancreatic duct brushing during endoscopy.
    Zhou GX; Huang JF; Zhang H; Chen JP
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):308-11. PubMed ID: 17548257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy.
    Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H
    Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
    Suehara N; Mizumoto K; Muta T; Tominaga Y; Shimura H; Kitajima S; Hamasaki N; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 1997 Jun; 3(6):993-8. PubMed ID: 9815776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
    Matsubayashi H; Canto M; Sato N; Klein A; Abe T; Yamashita K; Yeo CJ; Kalloo A; Hruban R; Goggins M
    Cancer Res; 2006 Jan; 66(2):1208-17. PubMed ID: 16424060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of telomerase activity of exfoliated cells in bile and its clinical impact].
    Yu SA; Peng CH; Wu RJ; Zheng ZD; Chen K; Fu ZN
    Ai Zheng; 2002 Feb; 21(2):177-80. PubMed ID: 12479071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay.
    Takaishi H; Kitamoto M; Takahashi S; Aikata H; Kawakami Y; Nakanishi T; Nakamura Y; Shimamoto F; Kajiyama G; Ide T
    Cancer; 2000 Jan; 88(2):312-7. PubMed ID: 10640962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
    Inoue H; Tsuchida A; Kawasaki Y; Fujimoto Y; Yamasaki S; Kajiyama G
    Cancer; 2001 Jan; 91(1):35-41. PubMed ID: 11148557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase activity is a useful marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts.
    Yeh TS; Cheng AJ; Chen TC; Jan YY; Hwang TL; Jeng LB; Chen MF; Wang TC
    J Surg Res; 1999 Dec; 87(2):171-7. PubMed ID: 10600346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
    Ohuchida K; Mizumoto K; Yamada D; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2066-9. PubMed ID: 16609017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas.
    Shirai Y; Sogawa K; Yamaguchi T; Sudo K; Nakagawa A; Sakai Y; Ishihara T; Sunaga M; Nezu M; Tomonaga T; Miyazaki M; Saisho H; Nomura F
    Hepatogastroenterology; 2008; 55(86-87):1824-9. PubMed ID: 19102401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic utility of aberrant methylation of tissue factor pathway inhibitor 2 in pure pancreatic juice for pancreatic carcinoma.
    Jiang P; Watanabe H; Okada G; Ohtsubo K; Mouri H; Tsuchiyama T; Yao F; Sawabu N
    Cancer Sci; 2006 Nov; 97(11):1267-73. PubMed ID: 16965396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification.
    Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K
    J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.